EP Patent

EP2604256A1 — Multi layer coatings

Assigned to Hexal AG · Expires 2013-06-19 · 13y expired

What this patent protects

The present invention refers to a process for the preparation of a coated particle comprising the provision a first and a second enteric coating layer, to a process for the preparation of a dosage form comprising said coated particle, and to a coated particle and a dosage form re…

USPTO Abstract

The present invention refers to a process for the preparation of a coated particle comprising the provision a first and a second enteric coating layer, to a process for the preparation of a dosage form comprising said coated particle, and to a coated particle and a dosage form respectively obtained according to the inventive process. Further, the present invention refers to a coated particle comprising a first and a second enteric coating layer, to a dosage form comprising said coated particle, as well as to the use of said dosage form as a medicament. Finally, the present invention refers to the use of a combination of a first enteric coating layer and a second enteric coating layer for the stabilization of an acid-labile API.

Drugs covered by this patent

Patent Metadata

Patent number
EP2604256A1
Jurisdiction
EP
Classification
—
Expires
2013-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Hexal AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.